Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honliv Healthcare Management Group operates and manages hospitals in China, primarily providing integrated medical, pharmaceutical, and hospital management services. Its flagship facility, Henan Honliv Hospital, offers comprehensive care across multiple specialties including obstetrics and gynecology, cardiovascular medicine, orthopedics, pediatrics, emergency medicine, hematology, dermatology, neurology among others. The company also engages in pharmaceutical sales to both inpatients and outpatients.
There are no clinical trial results or drug pipeline as the company does not develop therapeutics.
The group continues to focus on hospital accreditation upgrades and smart hospital construction while expanding specialty centers.
As of December 2024 it employed approximately 1,955 people with annual revenues around RMB769 million (~$106M USD).
It was listed on the Hong Kong Stock Exchange in July 2020.
Parent company is Sunny Rock Capital Limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Honliv Healthcare Management Group.